...
首页> 外文期刊>Clinical Pharmacology and Therapeutics >The pharmacogenomics research network translational pharmacogenetics program: Overcoming challenges of real-world implementation
【24h】

The pharmacogenomics research network translational pharmacogenetics program: Overcoming challenges of real-world implementation

机译:药物基因组学研究网络转化的药物遗传学计划:克服现实世界中的挑战

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The pace of discovery of potentially actionable pharmacogenetic variants has increased dramatically in recent years. However, the implementation of this new knowledge for individualized patient care has been slow. The Pharmacogenomics Research Network (PGRN) Translational Pharmacogenetics Program seeks to identify barriers and develop real-world solutions to implementation of evidence-based pharmacogenetic tests in diverse health-care settings. Dissemination of the resulting toolbox of "implementation best practices" will prove useful to a broad audience.
机译:近年来,发现可能起作用的药物遗传学变异体的步伐已大大增加。但是,针对个体化患者护理的这一新知识的实施进展缓慢。药物基因组学研究网络(PGRN)的转化药物遗传学计划旨在发现障碍并开发现实世界的解决方案,以在各种医疗保健环境中实施基于证据的药物遗传学检测。传播产生的“实施最佳实践”工具箱将证明对广大受众有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号